Search results
Results from the WOW.Com Content Network
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
1,4-Dimethylamylamine (1,4-DMAA), also known as 1,4-dimethylpentylamine or as 5-methylhexan-2-amine, is a stimulant drug of the alkylamine family related to methylhexanamine (1,3-DMAA; geranamine). [ 1 ] [ 2 ] It is naturally present in geranium plants and has also been found in certain other plants.
Octodrine, also known as dimethylhexylamine (DMHA) and sold under the brand name Vaporpac among others, is a sympathomimetic and stimulant medication that was formerly used in the treatment of hypotension (low blood pressure).
Side effects include irregular heartbeat, fatigue, high blood pressure, dry mouth, and eyes that are itchy, red, and/or swollen. Carbonic anhydrase inhibitors (Trusopt, Azopt): This is another ...
She also says to cautiously approach "anti-gray hair" supplements, as many of these aren't FDA-approved and can cause side effects. With this, Mertz warns against products that market with "scare ...
Since there is widespread use of these medications, it is important for people to be aware of all potential side effects and complications. However, since eye problems are very rare, it probably ...
Common effects, which vary depending on the substance and dosage in question, may include enhanced alertness, awareness, wakefulness, endurance, productivity, and motivation, increased arousal, locomotion, heart rate, and blood pressure, and the perception of a diminished requirement for food and sleep.
The supplement tricaprin, which is found in coconut or MCT oil, improved long-term survival for people with triglyceride deposit cardiomyovasculopathy, according to the results of a recent study.